-
oa Hydroxypropyl-β-Cyclodextrin Formulated in Nasal Chitosan Microspheres as Candidate Therapeutic Agent in Alzheimer's Disease
- Source: Current Drug Delivery, Volume 15, Issue 6, Jul 2018, p. 746 - 748
-
- 01 Jul 2018
Preview this article:




Hydroxypropyl-β-Cyclodextrin Formulated in Nasal Chitosan Microspheres as Candidate Therapeutic Agent in Alzheimer's Disease, Page 1 of 1
< Previous page Next page > /docserver/preview/fulltext/cdd/15/6/s3-1.gif
There is no abstract available.
© Bentham Science Publishers